4.5 Article

Cellular localization and functional significance of CYP3A4 in the human epileptic brain

Related references

Note: Only part of the references are listed.
Editorial Material Pharmacology & Pharmacy

Transporters in Drug-Refractory Epilepsy: Clinical Significance

N. Marchi et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)

Article Biochemistry & Molecular Biology

Localization of Drug-Metabolizing Enzyme Activities to Blood-Brain Interfaces and Circumventricular Organs

J. F. Ghersi-Egea et al.

JOURNAL OF NEUROCHEMISTRY (2010)

Review Clinical Neurology

The clinical impact of pharmacogenetics on the treatment of epilepsy

Wolfgang Loescher et al.

EPILEPSIA (2009)

Article Behavioral Sciences

Drug treatment of epilepsy: Options and limitations

Dieter Schmidt

EPILEPSY & BEHAVIOR (2009)

Review Clinical Neurology

Management of the patient with medically refractory epilepsy

Tiziana Granata et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)

Review Biochemistry & Molecular Biology

The pregnane X receptor: from bench to bedside

Xiaochao Ma et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)

Article Biochemistry & Molecular Biology

ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier

Sandrine Dauchy et al.

JOURNAL OF NEUROCHEMISTRY (2008)

Article Pharmacology & Pharmacy

Structural Basis of Human Pregnane X Receptor Activation by the Hops Constituent Colupulone

Denise G. Teotico et al.

MOLECULAR PHARMACOLOGY (2008)

Article Toxicology

Pregnane X receptor protects HepG2 cells from BaP-induced DNA damage

Christine Naspinski et al.

TOXICOLOGICAL SCIENCES (2008)

Review Biochemistry & Molecular Biology

Expression and function of cytochrome P450 in brain drug metabolism

R. P. Meyer et al.

CURRENT DRUG METABOLISM (2007)

Review Clinical Neurology

The blood-brain barrier and epilepsy

Emily Oby et al.

EPILEPSIA (2006)

Article Multidisciplinary Sciences

Pregnane X receptor (PXR) activation: A mechanism for neuroprotection in a mouse model of Niemann-Pick C disease

S. Joshua Langmade et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Neurosciences

MDR- and CYP3A4-Mediated Drug-Drug Interactions

Dhananjay Pal et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2006)

Review Neurosciences

Drug resistance in brain diseases and the role of drug efflux transporters

W Löscher et al.

NATURE REVIEWS NEUROSCIENCE (2005)

Article Clinical Neurology

Terminology and classification of the cortical dysplasias

A Palmini et al.

NEUROLOGY (2004)

Article Medicine, General & Internal

Significance of MDR1 and multiple drug resistance in refractory human epileptic brain

Nicola Marchi et al.

BMC MEDICINE (2004)

Article Oncology

Cytochrome P450 CYP3A4/5 expression as a biomarker of outcome in osteosarcoma

HR Dhaini et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)

Article Multidisciplinary Sciences

Antiepileptic drugs and apoptotic neurodegeneration in the developing brain

P Bittigau et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Pharmacology & Pharmacy

Interaction of cytochrome P450 3A inhibitors with P-glycoprotein

K Yasuda et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)

Article Multidisciplinary Sciences

Humanized xenobiotic response in mice expressing nuclear receptor SXR

W Xie et al.

NATURE (2000)

Review Pharmacology & Pharmacy

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition

GK Dresser et al.

CLINICAL PHARMACOKINETICS (2000)